Genzyme Corporation (GENZ) in Talks to Sell Itself to Takeda Pharmaceutical Co. Ltd. (TKDG.DE) for $18.5 Billion  
11/15/2010 7:40:21 AM

TOKYO (Dow Jones)--Japan's Takeda Pharmaceutical Co. (4502.TO) has explored whether it wanted to pursue a possible acquisition of U.S. biotechnology company Genzyme Corp. (GENZ), but is unlikely to do so, according to people familiar with the matter.